icad Inc (ICAD)
1.19
-0.08
(-5.93%)
USD |
NASDAQ |
Jul 02, 16:00
1.21
+0.02
(+1.68%)
After-Hours: 20:00
icad SG&A Expense (TTM): 16.19M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 16.19M |
December 31, 2023 | 17.42M |
September 30, 2023 | 18.99M |
June 30, 2023 | 20.86M |
March 31, 2023 | 22.10M |
December 31, 2022 | 23.38M |
September 30, 2022 | 25.42M |
June 30, 2022 | 26.56M |
March 31, 2022 | 26.46M |
December 31, 2021 | 25.54M |
September 30, 2021 | 24.94M |
June 30, 2021 | 23.20M |
March 31, 2021 | 21.86M |
December 31, 2020 | 22.43M |
September 30, 2020 | 22.21M |
June 30, 2020 | 22.86M |
March 31, 2020 | 23.10M |
December 31, 2019 | 21.08M |
September 30, 2019 | 20.68M |
June 30, 2019 | 19.09M |
March 31, 2019 | 17.70M |
December 31, 2018 | 17.81M |
September 30, 2018 | 15.83M |
June 30, 2018 | 16.48M |
March 31, 2018 | 17.67M |
Date | Value |
---|---|
December 31, 2017 | 18.38M |
September 30, 2017 | 19.13M |
June 30, 2017 | 18.71M |
March 31, 2017 | 18.67M |
December 31, 2016 | 17.85M |
September 30, 2016 | 17.80M |
June 30, 2016 | 18.51M |
March 31, 2016 | 19.27M |
December 31, 2015 | 21.19M |
September 30, 2015 | 22.12M |
June 30, 2015 | 23.03M |
March 31, 2015 | 22.27M |
December 31, 2014 | 20.51M |
September 30, 2014 | 19.57M |
June 30, 2014 | 17.89M |
March 31, 2014 | 17.09M |
December 31, 2013 | 16.92M |
September 30, 2013 | 16.10M |
June 30, 2013 | 16.66M |
March 31, 2013 | 16.81M |
December 31, 2012 | 16.94M |
September 30, 2012 | 17.49M |
June 30, 2012 | 18.13M |
March 31, 2012 | 21.39M |
December 31, 2011 | 23.68M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
16.19M
Minimum
Mar 2024
26.56M
Maximum
Jun 2022
22.38M
Average
22.43M
Median
Dec 2020
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 19.11M |
Predictive Oncology Inc | 11.44M |
Xtant Medical Holdings Inc | 72.60M |
Asensus Surgical Inc | 34.07M |
Catheter Precision Inc | 9.545M |